Biomarker Commons

Biomarker Commons is my knowledge curation project, where I continually find, organize and share the best and most relevant content on biomarkers. BiomarkerCommons.org provides consistent, high-quality news and research focused on biomarker discovery, development and use.

Recent articles by Walter Jessen on biomarkers

  • Covance Scientists to Present at the Molecular Med Tri-Con
    Monday, February 20th, 2012

    Scientists from Covance Discovery and Translational Services will be showcasing their company's R&D capabilities, talent and technologies in biomarkers, discovery services, genomics and proteomics to over 3,000 participants at the 2012 Molecular Med Tri-Con this week in San Francisco, CA. The Mo [...]


  • NYAS Symposium Review: Biomarkers and Brain Imaging of Presymptomatic Alzheimer's Disease
    Wednesday, February 01st, 2012

    The New York Academy of Sciences (NYAS) symposium, Biomarkers and Brain Imaging of Presymptomatic Alzheimer's Disease, was held last week Tuesday. About 150 people were in attendance consisting of a mix of academic and industrial researchers. [On a side note, the NYAS symposium office is located on [...]


  • Selventa Receives Patent for Method to Identify Biomarker Profiles
    Friday, January 27th, 2012

    Selventa, a biomarker discovery company that enables personalized healthcare through the stratification of patients based on disease-driving mechanisms, recently announced a US patent that relates methods and techniques that facilitate discovery of biomarkers, thus aiding in the development of predi [...]


  • SciClips Launches Cancer Biomarker Database
    Wednesday, January 04th, 2012

    The success of personalized cancer therapeutics relies on the development of companion diagnostic assays that can identify the most appropriate cancer patient, tumor type and disease state. To address this need, SciClips, a Wisconsin-based open innovation platform company that enables scientists and [...]


  • FDA Clears Critical Diagnostics Presage ST2 Assay for Patients with Heart Failure
    Friday, December 16th, 2011

    Critical Diagnostics is a U.S.-based biomarker company focused on optimizing patient care in cardiovascular diseases, such as heart failure. The San Diego-based company announced yesterday that they have received FDA approval for their Presage ST2 Assay for use as an aid in assessing the prognosis o [...]


  • The Bill & Melinda Gates Foundation to Fund Biomarkers of Gut Function for Global Health
    Monday, December 12th, 2011

    The Bill & Melinda Gates Foundation is currently seeking letters of inquiry for the grant program Biomarkers of Gastrointestinal (Gut) Function and Health. Letters of intent are due by January 11th, 2012 at 10:00 a.m. PST. The grant program is part of a new biomarker grand challenge under the Gr [...]